SCHEMBL6181043

SCHEMBL6181043

CC(C)(CCCC(O)CCCC(O)CCCC(C)(C)S(=O)(=O)O)S(=O)(=O)O

nearest known ligand 0.42

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.42
ACACA Q13085 1/20 0.42
FFAR4 Q5NUL3 1/20 0.31
FFAR1 O14842 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6181280 0.94 ACACB (0.41) ACACBACACA
SCHEMBL6179615 0.94 ACACB (0.50) ACACBACACAFFAR4FFAR1
SCHEMBL12945239 0.92 ACACB (0.53) ACACBACACAFFAR4FFAR1
SCHEMBL12092647 0.87 ACACB (0.44) ACACBACACAFFAR4FFAR1
SCHEMBL6199247 0.86 ACACB (0.36) ACACBACACA
SCHEMBL12092644 0.85 ACACB (0.47) ACACBACACAFFAR4FFAR1
SCHEMBL13053918 0.81 ACACB (0.31) ACACBACACA
SCHEMBL13053866 0.77 ACACB (0.30) ACACBACACA
SCHEMBL13106118 0.77 ACACB (0.36) ACACBACACA
SCHEMBL13106127 0.75 ACACB (0.39) ACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1597223-A2 HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2005-11-23 EP disclosed
WO-2004067489-A2 HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2004-08-12 WO disclosed